Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil dose-finding for apnea during pediatric cardiac MRI under general anesthesia
2014-004346-10Phase 4Unknown
- Sponsor
- Alder Hey Children's NHS Foundation Trust
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil, sponsored by Alder Hey Children's NHS Foundation Trust. Primary endpoint: Dose required for effective apnea. Status: unknown.
02
Drugs
remifentanil
Beyond the preview
Go deeper on 2014-004346-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004346-10.